Banca Mediolanum (BMED) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Net income for H1 2024 reached EUR 449.9 million, up 24% year-over-year, driven by higher fees, client growth, asset expansion, and robust profitability.
Customer acquisition set a new record with an 8% increase year-over-year, including 16,100 new digital customers and expansion of the Family Banker network.
Total assets under administration reached EUR 129.5 billion, up 15% year-over-year and 10% since year-end.
Strategic deposit promotions and targeted marketing fueled both customer and asset growth.
Maintained a simple, solid balance sheet and robust capital position, supporting growth and shareholder returns.
Financial highlights
Net commission income rose 15% to EUR 587.4 million, with management and investment management fees nearly EUR 743 million.
Net interest income reached EUR 480 million, up 20% year-over-year, but down 10% sequentially due to higher funding costs from deposit promos.
Operating margin hit a record EUR 566 million, up 22% year-over-year, with positive contributions from all business lines.
Total net inflows grew 21% to EUR 5.66 billion; managed asset inflows up 43% to EUR 3.09 billion.
Cost-income ratio improved to 39.2%.
Outlook and guidance
2024 net inflows into managed assets expected between EUR 6.5–7 billion, revised up from previous guidance.
NII guidance for 2024 is around +10% year-over-year; expected to be flat in 2025.
Cost-to-income ratio expected to remain around 40%.
Dividend expected to increase year-over-year, with high capital ratios supporting payout.
Continued focus on customer acquisition, digital expansion, and network development to drive medium-term AUM growth.
Latest events from Banca Mediolanum
- Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 10% YoY, record inflows, and strong capital ratios support 2025 outlook.BMED
Q1 20258 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20251 Nov 2025